Article info
PDFReview
Myeloid neoplasms post PARP inhibitors for ovarian cancer
- Correspondence to Dr Giuseppe Caruso, Department of Maternal and Child Health and Urological Sciences, University of Rome La Sapienza, Rome 00185, Italy; g.caruso{at}uniroma1.it
Citation
Myeloid neoplasms post PARP inhibitors for ovarian cancer
Publication history
- Received November 29, 2022
- Accepted January 17, 2023
- First published January 27, 2023.
Online issue publication
April 03, 2023
Article Versions
- Previous version (27 January 2023).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© IGCS and ESGO 2023. No commercial re-use. See rights and permissions. Published by BMJ.